HRTX
Price
$0.98
Change
-$0.05 (-4.85%)
Updated
Oct 2, 6:59 PM EST
37 days until earnings call
IMPL
Price
$0.41
Change
-$0.02 (-4.65%)
Updated
Oct 2, 6:59 PM EST
41 days until earnings call

HRTX vs IMPL ᐉ Comparison: Which is Better to Invest?

Header iconHRTX vs IMPL Comparison
Open Charts HRTX vs IMPLBanner chart's image
Heron Therapeutics
Price$0.98
Change-$0.05 (-4.85%)
Volume$1.27M
CapitalizationN/A
Impel Pharmaceuticals
Price$0.41
Change-$0.02 (-4.65%)
Volume$54.92K
CapitalizationN/A
View a ticker or compare two or three
HRTX vs IMPL Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
HRTX vs. IMPL commentary
Oct 03, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRTX is a Hold and IMPL is a Hold.

COMPARISON
Comparison
Oct 03, 2023
Stock price -- (HRTX: $1.03 vs. IMPL: $0.43)
Brand notoriety: HRTX and IMPL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRTX: 45% vs. IMPL: 8%
Market capitalization -- HRTX: $144.98M vs. IMPL: $9.31M
HRTX [@Biotechnology] is valued at $144.98M. IMPL’s [@Biotechnology] market capitalization is $9.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $407.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRTX’s FA Score shows that 0 FA rating(s) are green whileIMPL’s FA Score has 0 green FA rating(s).

  • HRTX’s FA Score: 0 green, 5 red.
  • IMPL’s FA Score: 0 green, 5 red.
According to our system of comparison, both HRTX and IMPL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRTX’s TA Score shows that 3 TA indicator(s) are bullish while IMPL’s TA Score has 4 bullish TA indicator(s).

  • HRTX’s TA Score: 3 bullish, 5 bearish.
  • IMPL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IMPL is a better buy in the short-term than HRTX.

Price Growth

HRTX (@Biotechnology) experienced а +1.98% price change this week, while IMPL (@Biotechnology) price change was -21.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.39%. For the same industry, the average monthly price growth was +18.43%, and the average quarterly price growth was +21.40%.

Reported Earning Dates

HRTX is expected to report earnings on Nov 08, 2023.

IMPL is expected to report earnings on Nov 13, 2023.

Industries' Descriptions

@Biotechnology (+0.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for HRTX with price predictions.
OPEN
A.I.dvisor published
a Summary for IMPL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
HRTX($145M) has a higher market cap than IMPL($9.31M). HRTX YTD gains are higher at: -58.800 vs. IMPL (-88.533). IMPL has higher annual earnings (EBITDA): -77.72M vs. HRTX (-139.64M). HRTX has more cash in the bank: 33.2M vs. IMPL (15.2M). IMPL has less debt than HRTX: IMPL (52.3M) vs HRTX (156M). HRTX has higher revenues than IMPL: HRTX (118M) vs IMPL (19M).
HRTXIMPLHRTX / IMPL
Capitalization145M9.31M1,557%
EBITDA-139.64M-77.72M180%
Gain YTD-58.800-88.53366%
P/E RatioN/AN/A-
Revenue118M19M621%
Total Cash33.2M15.2M218%
Total Debt156M52.3M298%
FUNDAMENTALS RATINGS
HRTX: Fundamental Ratings
HRTX
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HRTXIMPL
RSI
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SITM114.201.40
+1.24%
SiTime Corp
WDC45.63-0.17
-0.37%
Western Digital Corp
VJET1.05-0.01
-0.93%
voxeljet AG
TNP20.78-0.27
-1.28%
Tsakos Energy Navigation Ltd
TGAN2.22-0.12
-5.13%
Transphorm

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with MDGL. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
+6.19%
MDGL - HRTX
49%
Loosely correlated
-3.84%
DNA - HRTX
45%
Loosely correlated
+5.23%
BEAM - HRTX
44%
Loosely correlated
+0.12%
CRSP - HRTX
44%
Loosely correlated
-0.77%
AMRN - HRTX
44%
Loosely correlated
+1.12%
More

IMPL and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMPL has been loosely correlated with CYTK. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if IMPL jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMPL
1D Price
Change %
IMPL100%
-2.38%
CYTK - IMPL
33%
Loosely correlated
-4.35%
SRNEQ - IMPL
33%
Poorly correlated
-6.19%
FBIOP - IMPL
32%
Poorly correlated
-1.03%
MDGL - IMPL
32%
Poorly correlated
-3.84%
VXRT - IMPL
30%
Poorly correlated
+0.53%
More